Trial of the "Mittin" Intervention to Improve Contraceptive Side Effect Counseling and Follow-up in Ethiopia

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age15-49
SponsorUniversity of California, San Francisco

About this trial

The goal of this clinical trial is to learn if the "Mittin" intervention can improve women's ability to manage their fertility in line with their preferences among women aged 15-49 using hormonal contraceptives or intrauterine devices and attending public health centers in Addis Ababa, Ethiopia. The main question it aims to answer is: Does the Mittin intervention increase preference-aligned fertility management, contraceptive method satisfaction, and preferred contraceptive method use among participants compared to standard care?

Researchers will compare women's outcomes in health centers providing the Mittin intervention to women's outcomes in health centers that offer standard care to see if Mittin improves women's ability to act in line with their contraceptive preferences.

Participants will

* Receive either standard contraception services (control arm) or enhanced services (intervention arm) * Participate in a survey at the beginning of the study * Participate in surveys 4 and 8 months later

Eligibility criteria

Qualifiers

Woman

Started or continued using hormonal contraceptive method or copper IUD on day of recruitment

Ages 15-49 years

Willing to provide phone number and receive follow-up phone call

Disqualifiers

Not planning to live in Addis Ababa for the next eight months

Can not verbally communicate

Not willing to provide consent for the study

Trial design

Treatments tested in this trial

  • Mittin

Treatment groups

2,715 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of California, San Francisco

Lead sponsor

St. Paul's Hospital Millennium Medical College, Ethiopia

Collaborator

Bill and Melinda Gates Foundation

Collaborator